Prediction of Drug-likeness of Central Nervous System Drug Candidates Using a Feed-Forward Neural Network Based on Chemical Structure

31 August 2020, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Modern medical science has been greatly advanced by the development of new drugs, despite the fact that the process of developing new drugs is costly and time-consuming. An accurate prediction method for the drug-likeness in the early stage of drug discovery is highly desirable, as it will facilitate the discovery process and reduce the overall cost and eventually contribute to human well-being. Based on a central nervous system (CNS) drug dataset, we constructed an artificial neural network (NN) to predict the CNS drug-likeness of a given bioactive compound. We first constructed a simple feed-forward neural network, to learn and predict the possible correlations between twelve physiochemical properties and the CNS drug-likeness. The accuracy of prediction has reached 80%, which has been improved from previous reports. We further constructed a neural network based on chemical structure, and the accuracy has increased to 86%. The successful prediction of the CNS drug-likeness renders this NN a powerful tool for virtual drug screening.

Keywords

Central Nervous System
Drug-likeness
Drug screening
Neural Network
Artificial Intelligence

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.